Identifying newly approved medications in Medicare claims data: a case study using tocilizumab - Curtis, Jeffrey R.; Xie, Fenglong; Chen, Rui; Chen, Lang; Kilgore, Meredith L; Lewis, James D.; Yun, Huifeng; Zhang, Jie; Wright, Nicole C.; Delzell, Elizabeth (Pharmacoepidemiology and drug safety, 2013)
Keywords: Algorithms; Antibodies, Monoclonal, Humanized - administration & dosage; Antibodies, Monoclonal, Humanized - therapeutic use; Arthritis, Rheumatoid - drug therapy; Biological and medical sciences; biologics; certolizumab; Clinical Coding; Clinical trial. Drug monitoring; Cohort Studies; Databases, Factual; denosumab; Diseases of the osteoarticular system; Drug Approval; Drug therapy; General pharmacology; Humans; Inflammatory joint diseases; Injections; Insurance, Health, Reimbursement - statistics & numerical data; linkage; Medical coding; Medical sciences; Medicare; Part D; pharmacoepidemiology; Pharmacoepidemiology - methods; Pharmacology. Drug treatments; Registries; registry; rheumatoid arthritis; Sensitivity and Specificity; tocilizumab; United States; Tocilizumab; Diseases of the osteoarticular system; Autoimmune disease; Inflammatory joint disease; Monoclonal antibody; linkage; Epidemiology; Drug; Immunopathology; Health insurance; registry; Medicare; biologics; Treatment efficiency; Part D; certolizumab; Pharmacovigilance; Denosumab; Parenteral administration; pharmacoepidemiology; Case study; Immunomodulator; Chronic; Treatment; Register; Rheumatoid arthritis; Immunosuppressive agent; tocilizumab; rheumatoid arthritis; denosumab